CONTACT | Print Page | Sign In | Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 1 of 10
1  |  2  |  3  |  4  |  5  |  6  >   >>   >| 

Scientific Advancements
Tuesday, August 11, 2020   (0 Comments - view/add)
UCF Researchers Utilize Human-on-a-Chip® Approach to Model ALS Pathology »
UCF Researchers Utilize Human-on-a-Chip ® Approach to Model ALS Pathology...
Tuesday, August 11, 2020   (0 Comments - view/add)
Catalyst Pharmaceuticals Announces Notice of Allowance of a U.S. Patent Application for "Methods of »
  Catalyst Pharmaceuticals Announces Notice of Allowance of a U.S. Patent Application for "Methods of Adminis...
Thursday, August 6, 2020   (0 Comments - view/add)
FDA Approves Two Emergency INDs for COVID-19 Outpatient Therapy »
FDA Approves Two Emergency INDs for COVID-19 Outpatient Therapy First Reported eIND Issued for Outpatient COVID-19...
Thursday, August 6, 2020   (0 Comments - view/add)
Catalyst Pharmaceuticals’ Firdapse® (amifampridine phosphate) Receives Marketing Approval in Canada »
Catalyst Pharmaceuticals’ Firdapse® (amifampridine phosphate) Receives Marketing Approval in Canada for Patients with LEMS...
Wednesday, July 29, 2020   (0 Comments - view/add)
SMH Expands COVID-19 Antibody Cocktail Trial to People Recovering at Home »
SMH Expands COVID-19 Antibody Cocktail Trial to People Recovering at Home July 29,...
Tuesday, July 28, 2020   (0 Comments - view/add)
Hesperos demonstrates innovative Human-on-a-Chip® approach to modeling innate immune system response »
Hesperos demonstrates innovative Human-on-a-Chip® approach to modeling innate immune system response following tissue dama...
Monday, July 27, 2020   (0 Comments - view/add)
COVID vaccine study with 30,000 volunteers launched with Vice President Pence touting UM’s role in M »
COVID vaccine study with 30,000 volunteers launched with Vice President Pence touting UM’s role in Miami By Cindy K...
Thursday, July 23, 2020   (0 Comments - view/add)
Axogen RECON Clinical Study Completes Target Enrollment of 220 Subjects »
Axogen RECON Clinical Study Completes Target Enrollment of 220 Subjects RECON is a pivotal study supporting the Co...
Wednesday, July 22, 2020   (0 Comments - view/add)
AGTC Announces Updated Development Plan for its X-Linked Retinitis Pigmentosa Clinical Program, Incl »
AGTC Announces Updated Development Plan for its X-Linked Retinitis Pigmentosa Clinical Program, Including Q1 2021 Start of...
Wednesday, July 22, 2020   (0 Comments - view/add)
AGTC Announces Updated Development Plan for its X-Linked Retinitis Pigmentosa Clinical Program, Incl »
AGTC Announces Updated Development Plan for its X-Linked Retinitis Pigmentosa Clinical Program, Including Q1 2021 Star...
Wednesday, July 22, 2020   (0 Comments - view/add)
Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutral »
Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutralizing Antibodies...
Monday, July 13, 2020   (0 Comments - view/add)
Akron Biotech Submits eCTD Drug Master Files with FDA for Its Suite of cGMP Immunotherapy Cytokines »
Akron Biotech Submits eCTD Drug Master Files with FDA for Its Suite of cGMP Immunotherapy Cytokines Leading-Edge...
Wednesday, July 1, 2020   (0 Comments - view/add)
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vacci »
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against S...
Tuesday, June 30, 2020   (0 Comments - view/add)
GRDG Sciences and Chemia Corp. Announce 3F Biofragrance Success Against COVID-19 »
GRDG Sciences and Chemia Corp. Announce 3F Biofragrance Success Against COVID-19 WINTER HAVEN, Fla. , June 30, 2020...
Monday, June 29, 2020   (0 Comments - view/add)
Gift of Life Marrow Registry, Root, and Rutgers researchers launch crowd study of tissue match genes »
Gift of Life Marrow Registry, Root, and Rutgers researchers launch crowd study of tiss ue match genes in COVID-19...
Monday, June 29, 2020   (0 Comments - view/add)
Cytocom, Inc. Announces Successful Completion of Type-B Pre-IND Meeting with FDA Regarding Proposed »
Cytocom, Inc. Announces Successful Completion of Type-B Pre-IND Meeting with FDA Regarding Proposed Phase 2 Clinical Trial...
Monday, June 22, 2020   (0 Comments - view/add)
50% Complete Response Rate Observed in YourVaccx™ Study for Patients with Metastatic Prostate Cance »
50% Complete Response Rate Observed in YourVaccx ™ Study for Patients with Metastatic Prostate Cancer was Presented a...
Friday, June 12, 2020   (0 Comments - view/add)
Mutated coronavirus shows significant boost in infectivity »
Mutated coronavirus shows significant boost in infectivity COVID-19-causing viral variant taking over in the United St...
Wednesday, June 10, 2020   (0 Comments - view/add)
Dyadic and Frederick National Laboratory to Develop Cell Lines for COVID-19 Vaccine Candidates Using »
Dyadic and Frederick National Laboratory to Develop Cell Lines for COVID-19 Vaccine Candidates Using Dyadic'...
Thursday, June 4, 2020   (0 Comments - view/add)
Espero BioPharma, Inc. Expands Collaboration Effort for Tecarfarin »
Espero BioPharma, Inc. Expands Collaboration Effort for Tecarfarin JACKSONVILLE, Fla. and IRVINE, Calif. , June 4,...
Wednesday, June 3, 2020   (0 Comments - view/add)
Transparency Life Sciences and Lakewood Amedex Launch Protocol Design for New Clinical Trial on Chro »
Transparency Life Sciences and Lakewood Amedex Launch Protocol Design for New Clinical Trial on Chronic Diabetic Foot Ulce...
Tuesday, June 2, 2020   (0 Comments - view/add)
Relief Therapeutics and NeuroRx Announce Enrollment of First Patients with RLF- 100 in Phase 2b/3 Cl »
Relief Therapeutics and NeuroRx Announce Enrollment of First Patients with RLF- 100 in Phase 2b/3 Clinical Trial in Patien...
Tuesday, June 2, 2020   (0 Comments - view/add)
Hesperos demonstrates innovative Human-on-a-Chip® approach to modeling innate immune system response »
Hesperos demonstrates innovative Human-on-a-Chip® approach to modeling innate immune system response following tissue dama...
Monday, June 1, 2020   (0 Comments - view/add)
Longeveron Announces Japanese Approval of Clinical Trial for Treatment of Aging Frailty With Longeve »
Longeveron Announces Japanese Approval of Clinical Trial for Treatment of Aging Frailty With Longeveron's Stem Cells Th...
Monday, June 1, 2020   (0 Comments - view/add)
FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients »
FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients MIAMI, June 01, 2020 (GLOBE NEWSWIRE...
Monday, June 1, 2020   (0 Comments - view/add)
Aspire Health Science Announces US FDA Approval of IND Application Regarding Testing Proprietary ACT »
Aspire Health Science Announces US FDA Approval of IND Application Regarding Testing Proprietary ACT-20 Cellular Therapy A...
Friday, May 29, 2020   (0 Comments - view/add)
Hesperos Human-on-a-Chip® System Used to Model Preclinical Stages of Alzheimer’s Disease and Mild Co »
Hesperos Human-on-a-Chip ® System Used to Model Preclinical Stages of Alzheimer’s Disease and Mild Cognitive Impairment...
Wednesday, May 27, 2020   (0 Comments - view/add)
Lakewood-Amedex Receives Notice of Allowance for Two U.S. Patents Covering the Broad-Spectrum Antimi »
Lakewood-Amedex Receives Notice of Allowance for Two U.S. Patents Covering the Broad-Spectrum Antimicrobial Nu-8 Bisphosph...
Thursday, May 21, 2020   (0 Comments - view/add)
ADMA Biologics Commences Collection of COVID-19 Plasma from Recovered Patients »
ADMA Biologics Commences Collection of COVID-19 Plasma from Recovered Patients...
Wednesday, May 20, 2020   (0 Comments - view/add)
AGTC Announces Publication of Positive Preclinical Data that Provides Foundational Scientific Eviden »
AGTC Announces Publication of Positive Preclinical Data that Provides Foundational Scientific Evidence for its Ongoing Cli...
Wednesday, May 20, 2020   (0 Comments - view/add)
Cyclo Therapeutics Inc. Announces Positive Top Line Results from Phase I Trial and Interim Analysis »
Cyclo Therapeutics Inc. Announces Positive Top Line Results from Phase I Trial and Interim Analysis of Phase I/II Trial us...
Thursday, May 14, 2020   (0 Comments - view/add)
FDA approves COVID-19 trial after successful emergency use of umbilical stem cells from RESTEM »
FDA approves COVID-19 trial after successful emergency use of umbilical stem cells from RESTEM Clinical trials to begin...
Wednesday, May 13, 2020   (0 Comments - view/add)
Halodine® Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19) »
Halodine® Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19) FORT LAUDERDALE, Fla....
Tuesday, May 5, 2020   (0 Comments - view/add)
Organicell Announces FDA Approval of IND Application for the Treatment of SARS Due to COVID-19 »
Organicell Announces FDA Approval of IND Application for the Treatment of SARS Due to COVID-19   May 05,...
Monday, May 4, 2020   (0 Comments - view/add)
NDA Filing for Potential New ADHD Treatment, KP415, Accepted by FDA; KemPharm Eligible to Receive $5 »
NDA Filing for Potential New ADHD Treatment, KP415, Accepted by FDA; KemPharm Eligible to Receive $5 Million Milestone Pay...

Displaying page 1 of 10
1  |  2  |  3  |  4  |  5  |  6  >   >>   >| 

About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 6,700 establishments and research organizations in the BioPharma, MedTech, HealthIT & BioAg that collectively employ nearly 94,000 Floridians.